Bristol-Myers To Stop Selling Antibiotic With Safety Risk

Dow Jones - Apr. 27, 2006
By Peter Loftus

Of DOW JONES NEWSWIRES


Bristol-Myers Squibb Co. (BMY) has decided to stop selling an antibiotic that has safety problems and return the rights for the drug to the company's Japanese partner.

The New York pharmaceutical company will stop selling Tequin, which was found to increase the risk of blood-sugar problems. In February, Bristol-Myers strengthened the drug's label to warn of the potential for high and low blood-sugar levels, both of which can be fatal. It also recommended the drug not be taken by diabetics, who must control blood-sugar levels. Studies released last month confirmed ...

Full text can be found by following this link:

Bristol-Myers To Stop Selling Antibiotic With Safety Risk